Zobrazeno 1 - 10
of 54
pro vyhledávání: '"Paolo Di Giorgio"'
Publikováno v:
Energies, Vol 14, Iss 16, p 5116 (2021)
Microbial fuel cells (MFCs) have recently attracted more attention in the context of sustainable energy production. They can be considered as a future solution for the treatment of organic wastes and the production of bioelectricity. However, the low
Externí odkaz:
https://doaj.org/article/8e30703736c7400a97f9a016b0177f9e
Autor:
Paolo Di Giorgio, Umberto Desideri
Publikováno v:
Energies, Vol 9, Iss 8, p 662 (2016)
Electrical energy storage (EES) systems allow shifting the time of electric power generation from that of consumption, and they are expected to play a major role in future electric grids where the share of intermittent renewable energy systems (RES),
Externí odkaz:
https://doaj.org/article/df7b70290550487aa0aa5e46461dba12
Autor:
Laura Oggianu, Beatrice Garrone, Francesco Fiorentini, Francesca Del Bene, Maria Teresa Rosignoli, Francesco Paolo Di Giorgio, Rafal Marian Kaminski
Publikováno v:
Clinical and Translational Science, Vol 16, Iss 4, Pp 606-617 (2023)
Abstract A pharmacokinetic/pharmacodynamic (PK/PD) model was developed to describe the time course of writhings after intraperitoneal injection of acetic acid in mice. The model was applied to investigate the antinociceptive effect of trazodone and g
Externí odkaz:
https://doaj.org/article/ef97ad29d187425e8e3978539ad3e286
Autor:
Pamela R. Westmark, Beatrice Garrone, Rosella Ombrato, Claudio Milanese, Francesco Paolo Di Giorgio, Cara J. Westmark
Publikováno v:
Frontiers in Molecular Neuroscience, Vol 14 (2021)
Glycogen synthase kinase 3 (GSK3) is a proline-directed serine-threonine kinase that is associated with several neurological disorders, including Alzheimer’s disease and fragile X syndrome (FXS). We tested the efficacy of a novel GSK3 inhibitor AFC
Externí odkaz:
https://doaj.org/article/bb522fa51d7e4cfcba4890777d4264ff
Autor:
Alice Taddeucci, Guendalina Olivero, Alessandra Roggeri, Claudio Milanese, Francesco Paolo Di Giorgio, Massimo Grilli, Mario Marchi, Beatrice Garrone, Anna Pittaluga
Publikováno v:
Cells, Vol 11, Iss 19, p 3035 (2022)
The glutamatergic nerve endings of a rat prefrontal cortex (PFc) possess presynaptic 5-HT2A heteroreceptors and mGlu2/3 autoreceptors, whose activation inhibits glutamate exocytosis, and is measured as 15 mM KCl-evoked [3H]D-aspartate ([3H]D-asp) rel
Externí odkaz:
https://doaj.org/article/3fbfd7f8ec7d4a9a8721005b8c9d1f0a
Autor:
Beatrice Garrone, Anna di Matteo, Alessandro Amato, Luana Pistillo, Lucia Durando, Claudio Milanese, Francesco Paolo Di Giorgio, Serena Tongiani
Publikováno v:
PLoS ONE, Vol 16, Iss 1, p e0244649 (2021)
Neuropathic pain is a chronic debilitating condition caused by injury or disease of the nerves of the somatosensory system. Although several therapeutic approaches are recommended, none has emerged as an optimal treatment leaving a need for developin
Externí odkaz:
https://doaj.org/article/47d01d0e94f94e4781f98b371364cc85
Autor:
Laura Oggianu, Beatrice Garrone, Francesco Fiorentini, Francesca Del Bene, Maria Teresa Rosignoli, Francesco Paolo Di Giorgio, Rafal Marian Kaminski
Publikováno v:
Clinical and Translational Science. 16:606-617
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::924b2a2b38e8215a4fcfdc01d97175c5
https://doi.org/10.1111/cts.13472
https://doi.org/10.1111/cts.13472
Autor:
Noemi D'Atanasio, Alessandra Capezzone de Joannon, Laura Di Sante, Giorgina Mangano, Rosella Ombrato, Marco Vitiello, Cristina Bartella, Gabriele Magarò, Federica Prati, Claudio Milanese, Carla Vignaroli, Francesco Paolo Di Giorgio, Serena Tongiani
Publikováno v:
PLoS ONE, Vol 15, Iss 2, p e0228509 (2020)
In this study, a drug discovery programme that sought to identify novel dual bacterial topoisomerase II inhibitors (NBTIs) led to the selection of six optimized compounds. In enzymatic assays, the molecules showed equivalent dual-targeting activity a
Externí odkaz:
https://doaj.org/article/96e4320901204a7eb92810eea290642f
Autor:
Barbara Garofalo, Federica Prati, Rosa Buonfiglio, Isabella Coletta, Noemi D’Atanasio, Angela Molteni, Daniele Carettoni, Valeria Wanke, Giorgio Pochetti, Roberta Montanari, Davide Capelli, Claudio Milanese, Francesco Paolo Di Giorgio, Rosella Ombrato
Publikováno v:
Pharmaceuticals, Vol 14, Iss 7, p 612 (2021)
The major cause of bacterial resistance to β-lactams is the production of hydrolytic β-lactamase enzymes. Nowadays, the combination of β-lactam antibiotics with β-lactamase inhibitors (BLIs) is the main strategy for overcoming such issues. Nevert
Externí odkaz:
https://doaj.org/article/c8323392480c40b1bdc34407531be095
Autor:
Riccardo Cortese, Andrea Musacchio, Fabrizio Villa, Fabio Sessa, Marta Bartiromo, Francesco Paolo Di Giorgio, Mariangela Iovino, Giovanni Amabile, Anna Morena D'Alise
Supplementary Table S2 from Reversine, a novel Aurora kinases inhibitor, inhibits colony formation of human acute myeloid leukemia cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09e0291852a072fc5e31627fac04e078
https://doi.org/10.1158/1535-7163.22485806
https://doi.org/10.1158/1535-7163.22485806
